Patent ID: 11957687
Assignee: REGENERON PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 7:
8. A compound according to formula (VIII):, or a pharmaceutically acceptable salt thereof, wherein:
r and r′ are independently from 0 to 4;
R8 is independently at each occurrence halogen, —CN, ═O, —OH, —(CH2)0-3—SH, —(CH2)0-3—SR*, —(SO2)—R*, —NH2, —(CH2)1-3—OR#, —NH—(C═O)—R*, —NH—(SO2)—R*, —(CH2)1-3—NR#2, —NHR#, or —N(R#)2, C1-4 alkoxy, phenoxy, C1-12 alkyl, C1-12 alkenyl, C1-12 alkynyl, C1-4 haloalkyl, C1-4 haloalkoxy, C6-12 aryl, a 4-7-membered heterocycle with 1 to 4 heteroatoms selected from O, N and S or combinations thereof, or wherein two adjacent R8 groups form a 5-7 membered ring that optionally contains 1 to 3 heteroatoms selected from O, N, and S; any of which is optionally substituted with R*,
R* is halogen, —OH, C1-3 alkyl, C1-3 haloalkyl, phenyl, or benzyl, any of which is optionally substituted with a halogen; and
R# is C1-3 alkyl, C1-3 haloalkyl, C3-6 cycloalkyl, phenyl, or benzyl, any of which is optionally substituted with a halogen.